United States· US:71610-911_3662a842-9689-b3e3-e063-6394a90a15a9
Memantine Hydrochloride
A memantine product containing memantine hydrochloride, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Memantine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DX01 (memantine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Memantine · ATC N06DX01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of memantine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.22 in United States to $2.93 in Spain — a ×13 gap.
- United States: $0.22 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Memantine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- ES Spain$2.93
- CH Switzerland$2.47
- IT Italy$0.77
- US United States$0.22 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MEMANTINE HYDROCHLORIDE
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Country
- United States (US)
- ATC code
- N06DX01
- ATC class
- Memantine
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11716109116090 TABLET in 1 BOTTLE (71610-911-60)
- ndc117161091170120 TABLET in 1 BOTTLE (71610-911-70)
- ndc117161091180180 TABLET in 1 BOTTLE (71610-911-80)
- ndc1171610-911-60
- ndc1171610-911-70
- ndc1171610-911-80
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
139 interactions on record for memantine.
Graded by severity as the source publishes them — 42 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Memantine · interactions on record
139 records
- 42 moderate
- 11 minor
- 80 info
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
6 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Memantine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEbixa 5mg tabletsLundbeck Ltd
- CanadaPMS-MEMANTINEPHARMASCIENCE INC
- SwitzerlandMemantin-Mepha 5 mg, LactabMepha Pharma AG
- SpainMEMANTINA KERN PHARMA 5 MG + 10 MG + 15 MG + 20 MG COMPRIMIDOS EFGKern Pharma S.L.
- CzechiaAXURAMerz Pharmaceuticals GmbH, Frankfurt am Main
- PolandAuroMemoAurovitas Pharma Polska Sp. z o.o.
- NetherlandsAlsemora 10 mg filmomhulde tablettenGrindeks AS
- FinlandAdaxor AloituspakkausAvansor Pharma Oy
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Alsemora, Memantin 1a Pharma
- Belgium · Alsemora, Memantine Eg
- Bulgaria · Memantine Grindeks, Имана
- Cyprus · Alzedem, Mantomed
- Czechia · Cognomem, Mantomed
- Germany · Alsemora, Memantin
- Denmark · Alsemora, Marbodin
- Estonia · Alsemora, Mantomed
- Spain · Alsemora, Mantinex
- Finland · Alsemora, Marbodin
- France · Alsemora, Memantine Arrow Lab
- United Kingdom (Northern Ireland) · Memantine, Memantine Dawa
- Greece · Almerzac, Alsemora
- Croatia · Alsemora, Mantomed
- Hungary · Memantin Goodwill, Memantin Stada
- Ireland · Memantine Clonmel, Memantine Grindeks
- Iceland · Axura, Ebixa
- Italy · Demenco, Ezemantis
- Liechtenstein · Axura, Memantine Accord
- Lithuania · Alsemora, Maryzola
- Luxembourg · Memantine Eg
- Latvia · Alsemora, Mantomed
- Malta · Memantine Aurobindo, Memantine Clonmel
- Netherlands · Alsemora, Mantomed
- Norway · Alsemora, Axura
- Poland · Auromemo, Biomentin
- Portugal · Alsemora, Mantinex
- Romania · Alsemora, Memantina Atb
- Sweden · Alsemora, Marbodin
- Slovenia · Alsemora, Mantomed
- Slovakia · Alsemora, Mantomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2298b96-37ad-4d74-adb9-aa4e6d4b0d35 GET /v1/drugs/d2298b96-37ad-4d74-adb9-aa4e6d4b0d35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "5",
"substance": "MEMANTINE HYDROCHLORIDE",
"productndc": "71610-911",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA090961",
"marketing_category": "ANDA"
}See everything about memantine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.